We investigated the transduction, protein expression, viral replication and oncolytic efficacy of the novel Ad11p vectors and demonstrated that the oncolytic activities of the ADP vector include tumour-specific cell killing and that this effect is dependent on ADP and E1A gene expression as well as viral replication ability in targeted cells. This evidence concerns the gene DHTKD1 and neoplasm.